Spring 2024 Newsletter
In This Issue:
- President’s Message
- ACMS Happenings
- Ask Glenn: Incision without Excision and 88342 Denials for Melanoma Mohs Cases
- Hot Topics: Medicare Cuts: Updates and What To Expect
- Viewpoints: An Interview with Dr. Peter Prieto of Iovance Biotherapeutics on TIL Therapy
- Mohs Around the World: Preview of the International Mohs Surgery Symposium: Perspectives from Around the World
- Highlights From the Literature:
- Practice Tips and Efficacy: The DermSurgery Digest Podcast
- Fellow-in-Training Perspective: Advice from Early-Career Mohs Surgeons on Building a Successful Mohs Practice
President’s Message
Dear Colleagues –
I write my last letter to you, perhaps like many past presidents, with a wonderful mix of emotions. I am excited for our annual meeting next week and look forward to gathering with over 1,200 of you who have registered—the largest anticipated in-person attendance ever at the pinnacle of our educational mission. At the same time, it is hard to believe how time has flown since I addressed you in Seattle last May. Many of my messages have been punctuated by noting the passage of time along with ACMS activities. And a year to serve this beloved organization so many of us call home is definitely not enough. Virtually all initiatives start as a creative seed with one leadership team, mature and come to fruition under another executive committee. Fortunately, the life and growth of the College is beyond any one presidency or executive term. What links each administration to the next and ultimately unites it with the larger membership is the steadfast effort to make the ACMS better and stronger. Each President brings their unique flavor and attributes to impact the continual evolution of the College. One of my core missions has been to leverage the talent of our organization to provide resources that standardize and elevate the work we all do.
As I reflect on the accomplishments of the College, I appreciate that even if I were to use the space of the rest of the message simply to recount all the names of individuals that contributed, it would be insufficient. I am so very grateful to the Board of Directors, the numerous committee chairs and members, the ad hoc task forces and the entire ACMS administrative team. This year we responded quickly to advertisements from radiation therapy companies that were misleading and disparaging of Mohs surgery. This battle is ongoing. We must remain vigilant. We must anticipate and work towards providing evidence-based data for what is best for our skin cancer patients, including reminding policy makers of the most effective, value-based, cost-conscious care. The Public Relations Committee and our Senior Communications Manager, Aaren Johnson, took on the Herculean task of creating an entirely new patient-friendly and patient-facing website that will be launched soon. We want the public to prioritize our website as their first and best source of information for skin cancer and to understand why a fellowship-trained Mohs surgeon is the best physician to manage their skin cancer. Our aim is to have the ACMS website link to every member’s professional website in the surgeon finder directory and have member websites link back to the College’s to optimize search engine ranking - a longstanding goal of the College.
The website will also house several resources we initiated for the membership, including our new and expanding ACMS Video Library. The content of this library has started with concise, vetted instructional videos on various reconstructive flaps. It will eventually include both a variety of surgical procedures as well as Mohs tissue processing techniques. Learn more about this project and the thoughtful work of the CME and Education Committee members at this link on our current website: ACMS Video Library. One of the unique aspects of our training is that it can feel like a solitary apprenticeship with knowledge and skills passed on generationally from one or two mentors. Alternatively, including and sharing educational content from our talented membership that is diverse in experience and perspective is a way to broaden and advance individual surgical expertise beyond our experience in one fellowship. I thank the talented ACMS members who have and will generously contribute to this educational endeavor. A submission process has been created for members to share videos to be considered for the library. If you are interested in submitting a video, I welcome you to review the content submission guidelines and content areas. The guidelines are precise and firm to ensure this resource is focused on the College’s core mission and meets the highest standards in dermatologic surgery education. Submissions will be reviewed four times per year, with the first content submission deadline on June 1.
I am also excited to announce the launch of the ACMS Diversity Mentorship Program. Initially proposed by a Mohs Surgeons Leading the Future project group, this program is designed to increase the exposure underrepresented minorities in medicine have to Mohs surgery. By pairing an ACMS member with a mentee at an ACGME-approved dermatology residency, the College can help build a future for our specialty that is fully representative of our nation and of our patients. Numerous studies across multiple industries demonstrate that diverse leadership and inclusion have positive, holistic impact on workforce, communities, and the environment (and even financial returns). The first year of the mentorship program will run from September 2024 to August 1, 2025, and will consist of quarterly virtual meetings between all mentors and mentees with more frequent one-on-one meetings between individual mentor and mentee pairings. To learn more about the program, apply to be a mentor, or share mentee information with a dermatology resident, I encourage you to visit the program’s webpage. Applications will be accepted through June 30, 2024.
Whether it is taking steps to become more engaged global neighbors, creating resources for physicians and patients to understand Mohs surgery’s superiority, bolstering the impactful work of the ACMS Foundation and Mohs Surgeons Leading the Future (just wait and see what they have in store for you in Phoenix!), or carefully developing new initiatives like those announced in this message, I am confident that the College’s standing in medicine, our passion for innovation and improvement, and our commitment to our patients has never been greater. Serving as President of this organization and interacting with you all, its inspirational and engaged members, has been one of the highpoints of my professional career. I am grateful for your trust in me and will humbly continue to serve this organization in whatever capacity I can.
I look forward to seeing where we can go from here TOGETHER.
With gratitude,
Sumaira Z. Aasi, MD, FACMS
ACMS President, 2023-24
president@mohscollege.org
Read this and past President's Messages
MedPAC Policy Approaches to Address Physician Payment Updates
At their last meeting for the 2023-2024 cycle, the Medicare Payment Advisory Commission (MedPAC) put forward three approaches to address physician payments. Under the first approach, the PE component of the Physician Fee Schedule (PFS) would be updated by the hospital market basket index minus productivity. This approach aims to minimize the financial incentive for service consolidation and ensure PE payments reflect real costs. For dermatology, which often involves high PE due to the use of specialized equipment and materials, this adjustment could result in increased reimbursements that better reflect operational costs in a private office setting. In fact, MedPAC’s analysis shows a 15.5% projected average cumulative update for the specialty over 2024 - 2033. Under the second approach, the PFS would be updated annually by the Medicare Economic Index (MEI) minus one percentage point, with a floor of ½ of MEI. The goal of this option is to standardize updates, tying them more closely to economic conditions, and help maintain consistent provider participation in Medicare. The last approach aims to support the shift toward high-quality, cost-effective care, by extending the bonus for clinicians in Advanced Alternative Payment Models (APMs), which is currently set at 1.9%. The Commission also discussed eliminating 10 and 90 day global surgery codes to address concerns about the accuracy of payments for post-operative visits. MedPAC will include an informational chapter in the June 2024 Report to the Congress and continue discussions in the fall, possibly making recommendations in the 2024-2025 cycle.
See previous Advocacy Updates here
2024 Annual Meeting: What to Know
The College’s 2024 annual meeting begins next week. Online preregistration has closed, but onsite registration will be available at the hours listed here.
Annual Meeting App
Before arriving in Phoenix, download the all new ACMS annual meeting app. Build a custom agenda, view the Morning Mini-Sessions you’ve registered for, participate in Q&A, and more – visit www.mohs.net/app today to download the app.
Final Program
Want a preview of everything this year’s meeting has to offer? Use the app or visit www.mohs.net/24program to view the final program for this year’s meeting.
Q&A
Slido will again be used for Q&A at this year’s meeting. Slido can be accessed in the annual meeting app or by using QR codes on room signs at the annual meeting.
We look forward to seeing you in Phoenix next week.
ACMS Foundation Update | Mohs Surgeons Leading the Future 2024-25
Established during the College's 50th Anniversary Year in 2018, the ACMS Foundation aims to support the next 50 years of growth for our specialty. Mohs Surgeons Leading the Future (MSLF) is the Foundation’s one-year leadership program. Open to ACMS members at all stages of their career, MSLF participants learn valuable leadership skills, get connected to and build relationships with ACMS leadership, and receive one-on-one mentoring from a highly regarded leader in Mohs surgery. In addition, program participants work in small groups on a project in support of the College’s mission.
MSLF is a win-win program. By creating a pipeline for the next generation of leaders within the ACMS while creating member resources such as the postoperative digital flipbook for patients, MSLF lets ACMS members benefit from the leadership training and career development of the subspecialty’s future leaders.
Here are the recently announced mentors and participants for the 2024-25 MSLF program:
| Participants | Mentors |
| Kimberly Brady, MD, FACMS | Sarah Arron, MD, PhD, FACMS |
| Sama Carley, MD | Elizabeth Billingsley, MD, FACMS |
| Kimberly Ken, MD | Jeremy Bordeaux, MD, MPH, FACMS |
| Daniel M. Klufas, MD | Jerry Brewer, MD, MS, FACMS |
| Jordan Lim, MB BCh BAO | Christopher J. Miller, MD, FACMS |
| Kathryn Potter, MD, FACMS | Kishwer S. Nehal, MD, FACMS |
| Adam Sutton, MD, MBA, FACMS | Rajiv Nijhawan, MD, FACMS |
| Nicole Vélez, MD, FACMS | Christine Poblete-Lopez, MD, FACMS |
Contribute to the Foundation to support the future of Mohs surgery
2024 Board Election Results
Congratulations to the newly elected ACMS members who will soon join the board of directors. Dr. Christopher Miller has been elected secretary/treasurer for 2024-25. Drs. Todd Holmes, Joseph Sobanko, and Marta Van Beek have been elected board directors and will serve three-year terms that begin at the 2024 annual meeting in Phoenix.
Christopher Miller, MD, FACMS
|
|
|
|
ASMH Advanced Mohs Tech Training
The ASMH will be hosting a summer Advanced Mohs Tech Training from June 27-28, 2024. You can learn more and register your tech here. These on-site trainings will include lecture and hands-on training on topics such as mapping and inking, embedding, staining, cryosectioning, CLIA regulations, troubleshooting, and more.
Learn more and register your tech on the ASMH website
Click an image to learn more:
Invitations for Journal Club meetings are sent to an opt-in mailing list. To join the list and receive invitations to future meetings, click here or the click image above.
Did you recently publish an article that you believe your colleagues should be aware of? You can submit your article to pr@mohscollege.org to be considered for inclusion in the Cutting Edge, the College’s biweekly news brief. To submit your article, share a link to it along with a 3-4 sentence statement on its importance and any relevant context. Click here to submit your article for consideration.
Save the date for our 57th annual meeting in Nashville, May 15-18, 2025.
ASK GLENN — Answers to Your Mohs Coding & Billing Questions
Incision without Excision and 88342 Denials for Melanoma Mohs Cases
Responses provided by Glenn D. Goldman, MD, FACMS
Many ACMS members have questions about proper coding and billing for Mohs surgery. This reinforces a need for ongoing education to ensure the College meets its goal of integrity and ethics in all aspects of Mohs practice. The College's Past President, Dr. Glenn D. Goldman answers these coding and billing questions submitted to askglenn@mohscollege.org. Responses are included in the e-Newsletter for the benefit of all members.
ACMS Member Question:
How would you code this scenario?
A patient presents for cyst excision. An incision was made in the skin. No cyst is found of cutaneous origin. I explored the subcutaneous fat. A nodule is noted deep to the SMAS. The excision was terminated due to concern for injury to surrounding structure. Wound was repaired (intermediate closure) and referral to ENT was sent.
How would you code this? An excision and closure was intended but nothing was removed.
Read the answer and view other recent AskGlenn questions here
Medicare Cuts: Updates and What To Expect
By Mariam Mafee, MD, FACMS
More than 65 million people—nearly 20% of the U.S. population—receive their health insurance coverage through the federal Medicare program. Each year, the Centers for Medicare and Medicaid Services (CMS) updates Medicare payments to physicians and other clinicians through rulemaking, based on parameters established under law. CMS recently finalized payment changes for 2024, including increases in payment for a range of services related to primary care, behavioral health, and direct patient care. Due to a statutory requirement that CMS preserve budget neutrality when adjusting physician payment rates, these service-specific increases necessitated a decrease to the fee schedule conversion factor to offset additional costs.
In November 2023, CMS finalized a 3.4% decrease in the physician fee schedule conversion factor. This decrease was placed on top of conversion factor decreases of 3.3%, 0.8%, and 2% in 2021, 2022, and 2023 respectively. The Medicare conversion factor also has no provision for inflation adjustment. Given that a high proportion of patients with skin cancer are senior citizens, Mohs surgeons’ practices are highly dependent on Medicare insurance payments. The present Medicare payment system has placed enormous financial strain on Mohs surgeons’ offices and threatens U.S. seniors’ access to the highest quality skin cancer care.
To better understand the current state of affairs and what we can anticipate, we discussed updates with Matt Duckworth, Vice President of Government Relations at Hart Health Strategies Inc.
Continue reading 'Medicare Cuts: Updates and What To Expect' here
An Interview with Dr. Peter Prieto of Iovance Biotherapeutics on TIL Therapy
By Sherrif F. Ibrahim, MD, PhD, FACMS
On February 16, 2024, Iovance Biotherapeutics received FDA accelerated approval for Amtagvi (lifileucel) for the treatment of unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. This is a first-in-class treatment using a patient’s own tumor infiltrating lymphocytes (TIL) for previously treated advanced melanoma. I had the privilege of speaking with Dr. Prieto about this exciting news.
SI: Can you tell me a little bit about what Iovance does?
PP: Iovance is a global leader in innovating, developing and delivering T-cell therapies for solid tumors. We are the only pharmaceutical company to have translated TIL technology out of the research world to a now commercially available treatment.
SI: Can you give me an overview of how TIL therapy works?
PP: Amtagvi and our pipeline look at isolating a patient’s own lymphocytes from their tumor and giving them back to the patient in diseases such as metastatic melanoma, non-small cell lung cancer, endometrial cancer, cervical cancer, and head and neck cancers and in the case of melanoma we’ve now been able to scale this up to be able to deliver it across the country and soon to other places in the world.
SI: How was TIL therapy first developed?
PP: This technology was pioneered by a surgeon – my former mentor – Dr. Steven A. Rosenberg, who is the chief of the Surgery Branch, National Cancer Institute of the NIH. During my residency at Yale, I was able to work in the lab of Dr. Rosenberg. He taught me that you could cure cancer with the immune system. He was taking metastatic tumors from patients that were told they had weeks to live, isolating the tumor infiltrating lymphocytes, expanding them in the lab (to the billions), and then giving them back to the patient after a preparative lymphodepletion regimen. At the time of infusion and by design these are the only lymphocytes circulating in their bodies. And he saw response rates that were pretty phenomenal. Our outcomes at Iovance have also been very exciting as evidenced by our label for Amtagvi which is supported by response rates of 31.4%.
Continue reading 'An Interview with Dr. Peter Prieto of Iovance Biotherapeutics on TIL Therapy' here
Preview of the International Mohs Surgery Symposium: Perspectives from Around the World
By Christie Regula, MD, FACMS
At this year’s annual ACMS meeting, the College is hosting the first ever International Mohs Surgery Symposium. Taking place on Wednesday, May 1, from 4-6 p.m., this symposium will bring together Mohs surgeons from around the world with the goal of gaining a better understanding of the challenges and successes of international Mohs surgery practices. ACMS president, Dr. Sumaira Aasi, organized this first International Mohs Surgery Symposium and believes that “the ACMS should be at the forefront of helping to standardize how Mohs surgery is done globally.”
The session will feature four speakers, Krisinda C. Dim-Jamora, MD from the Philippines, Walayat Hussain, MD, FACMS from the United Kingdom, Felipe B. Cerci, MD, MSc from Brazil and Pieter J. du Plessis, MBChB, MMed, FC Derm from South Africa. These speakers will share the challenges that they face in their surgical practice, some shared and some unique, due to their location, healthcare system, and demographics amongst other factors. Some of these challenges include inconsistency or lack of Mohs training programs, reimbursement issues, scope of practice limitations, particularly in reading their own pathology, and their perceived value to the healthcare system as a whole. Luckily, we no longer face most of these issues in the United States and it is a privilege that we may often take for granted. While we cannot help to change international healthcare systems or national guidelines, we can provide a community for discussion of these challenges and resources to help international Mohs surgeons further the specialty in their own countries. ...
Continue reading 'Preview of the International Mohs Surgery Symposium' here
HIGHLIGHTS FROM THE LITERATURE
Postoperative Bleeding Complications Associated With Novel Oral Anticoagulants in Mohs Micrographic Surgery.
By Ramona Behshad, MD, FACMS
The study investigated postoperative bleeding complications linked to novel oral anticoagulants (NOACs) in Mohs Micrographic Surgery (MMS). Conducted by Fahmy et al. and published in Dermatologic Surgery, it aimed to assess the safety of performing MMS in patients on NOAC therapy. The researchers conducted a retrospective review of patients undergoing MMS at a dermatologic surgery center over a five-year period. The primary objective was to determine if there was a significant difference in the rate of postoperative bleeding complications between patients on NOAC therapy and those not on anticoagulant therapy.
Between January 2017 and July 2022, 2,530 cases of Mohs Micrographic Surgery (MMS) were conducted by a single surgeon. After excluding cases with outside repair and no follow-up, 2,181 MMS cases involving 1,545 unique patients were analyzed. There were 696/2181 cases (31.9%) in which patients were taking at least 1 type of antithrombotic medication. Among these, 22 cases (1.01%) experienced bleeding complications, comprising 19 hemorrhages and 3 hematomas. Age, sex, tumor location, number of stages, repair type, and defect size did not differ significantly between cases with and without bleeding complications. ...
Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single Center Retrospective Cohort Study
By Arif Aslam, MBChB, FRACP, FACD
Novel direct oral anticoagulants and antiplatelet agents are now more commonly prescribed worldwide, and it's estimated that 40% of patients undergoing Mohs surgery are taking either an antiplatelet or anticoagulant agent. These agents are associated with a higher risk of postoperative bleeding in addition to more complex repairs. Tranexamic acid (TXA) is a low-cost antifibrinolytic agent that stabilizes fibrin matrices by preventing the conversion of plasminogen to plastic, therefore preventing fibrin degradation. Its local use has been reported as a method of controlling bleeding in several surgical subspecialties.
The aim of this retrospective study was to assess bleeding events after interpolated flap repair in patients receiving TXA as a local injection into a pedicle compared to those who did not. A bleeding event was divided into major and minor. A major event was defined as all unplanned medical visits to address postoperative bleeding and a minor event included unplanned patient phone calls or messages specific for bleeding through the electronic medical record. Over a five-year period, of the 115 patients who underwent interpolated flap repairs, 21 (18.3%) received subcutaneous TXA injection at the time of flap placement. 18 of these underwent repair with a forehead flap and three a cheek-nose flap. Of note, 85.7% of the TXA group were forehead flaps and 71.3% of the non-TXA group were cheek-nose. The results show the number of bleeding events was low with the injection of TXA and was significantly higher in the non-TXA patients undergoing a forehead flap repair.
Whilst this study was a single-institution non-randomized retrospective review, it did show that subcutaneous TXA, which is relatively inexpensive, given directly into a pedicle flap can significantly lower rates of bleeding.
This paper also highlights the importance of meticulous surgical technique for hemostasis with either cautery of every single bleeding point or the use vessel ties during interpolated flap repairs.
Read an archived version of 'Tranexamic Acid Prevention of Hemorrhagic Complications...' here
The DermSurgery Digest Podcast
By Jeffrey F. Scott, MD, FACMS
Within the expanding landscape of medical podcasts, the DermSurgery Digest podcast emerges as a premier resource for Mohs surgeons wishing to stay abreast of the latest practice trends, techniques, and research in the field. Hosted by Dr. Naomi Lawrence, the DermSurgery Digest podcast features concise reviews of journal articles from each month’s issue of Dermatologic Surgery. The podcast began in 2022 with an average of 100-200 listeners per episode - it now attracts over 500 listeners per episode and is readily available for free subscription on Apple and Spotify. Whether you are commuting to the office, enjoying lunch, or relaxing, the DermSurgery Digest podcast offers Mohs College members a unique and convenient platform to consume educational material “on-the-go.”
I recently had the opportunity to discuss the origin of the podcast with Dr. Lawrence and highlight how it is beneficial to members of the Mohs College. Dr. Bill Coleman, editor of Dermatologic Surgery, appointed Dr. Lawrence to the multimedia editor position about six years ago. She began by producing podcasts on interesting articles published in the journal, but she describes that it was difficult to gain momentum and awareness of these early isolated podcasts because the content was not released on a regular basis. The turning point occurred when Dr. Lawrence was studying for the Mohs board exam, and she listened to Dr. Thomas Knackstedt’s excellent podcasts based on the Mohs College’s study guide. This reminded her “that podcasts are a great way to take in information and augment learning.” Dr. Lawrence discussed the idea of producing a regularly occuring podcast containing monthly summaries of articles in Dermatologic Surgery with her fellow at that time, Dr. Michael Renzi, and he “enthusiastically agreed to coedit and recruit a group of reviewers who had expertise in surgery and oncology, or in cosmetic procedures.” The first DermSurgery Digest podcast was published in February 2022.
The podcast format features an expert reviewer who summarizes three or four articles, primarily from Dermatologic Surgery, but it has evolved over the past couple of years. Dr. Lawrence’s next fellow, Dr. Yesul Kim, “had the idea to cover surgical articles of interest outside of the Dermatologic Surgery journal.” The goal was to “create a repository that made it easy for people to keep current on all surgical literature,” and the initial “beyond” Derm Surg content was incorporated into the main podcast episode in November 2022. In March 2024, the “beyond” content was separated out as standalone bonus content. More recently, after sharing a session with Dr. Ashley Elsensohn at an ASDS meeting, Dr. Lawrence “came up with the concept for our third podcast focused on dermatopathology pertinent to the practice of Mohs surgery.” The inaugural bonus content issue of “At the Microscope” was published in February 2024, and Dr. Lawrence now anticipates this new content to be released quarterly.
Continue reading 'The DermSurgery Digest Podcast' here
FELLOW-IN-TRAINING PERSPECTIVE
Advice from Early-Career Mohs Surgeons on Building a Successful Mohs Practice
By Callie Hill, MD, Fellow-in-Training Board Observer
As we approach the final months of fellowship, I find myself wondering “How can I transition from training to building a Mohs practice?” To answer this question, I had the privilege of interviewing three talented early-career Mohs surgeons who shared their experiences in academic and private practice Mohs surgery. Dr. Basia Michalski-McNeely (Mohs Fellowship: Cleveland Clinic, 2022) is an Assistant Professor in Mohs Surgery and Cosmetic Dermatology at Washington University in St Louis, MO. Dr. Rachel Kyllo (Mohs Fellowship: Northwestern, 2019) is the co-founder of Meramec Dermatology in Arnold, MO. Dr. Blake Phillips (Mohs Fellowship: University of Alabama at Birmingham, 2017) practices Mohs surgery at Total Dermatology in Birmingham, AL. From clinic management pearls to tips on establishing a relationship with referring providers, these surgeons shared applicable advice on navigating practice outside of fellowship.
In your first few years since fellowship, what practice pearls have you acquired that promote efficiency and flow in your Mohs surgery clinic?
Dr. Michalski-McNeely: “Communication is key to promoting effective teamwork. Clear and respectful communication with members of your Mohs team fosters a collaborative work environment and improves efficiency.”
Dr. Rachel Kyllo: “Adequate staffing with superior medical assistants and histotechnicians. Seeing a high volume of patients requires a ‘well-oiled machine’ with staff who are well trained and extremely capable to keep things running on schedule. Take time to cultivate a positive staff culture centered around excellence in patient care. Not all medical assistants that you hire will ‘make it’ - culling the bad apples from your team earlier rather than later is important to avoid other staff members from becoming disillusioned.
“During the first one to two years out of fellowship, you'll learn a ton about yourself as a surgeon and how you prefer to operate outside of training. Listen to your gut feelings those first couple of years and hone your schedule to fit how you want to practice.”
Dr. Blake Phillips: “When starting out a career, sacrifice surgical volume for optimized staff training. Grow slowly and avoid mistakes. Establish clear staff expectations from day one. Spend as much (or more) time improving your team dynamic and staff training rather than improving your personal surgical pace. You should be willing and capable of performing any tasks on the surgical team, but should avoid the potential pitfall of routinely stepping in to complete the tasks when tasks are not performed to your taste (much better to give feedback). It is very difficult to change the expectations of your staff once practice patterns are established. If there are tasks that you would optimally delegate in a high-volume practice, begin delegating them as early as you have the staff in place to do so.”
Mohs Surgery Career Center
Visit careers.mohscollege.org to search, apply for, and post open Mohs-related positions
The ACMS/ASMH Mohs Surgery Career Center is a resource for surgeons, histotechs, physician assistants, dermatopathologists, practice managers, administrative staff and others to search for job openings, post resumes, and connect with employers. The Career Center includes positions in multiple categories, expanded national reach, and the ability to search by position type, work setting, and state.
The Cutting Edge provides the latest news relevant to Mohs surgeons. Delivered biweekly via email, this news brief includes scannable summaries of content available on the ACMS website and elsewhere.
Please note that The Cutting Edge is sent as an email from acms@multibriefs.com. Please add this domain to your safe senders list to ensure delivery.
Follow the ACMS on Social Media
